227 related articles for article (PubMed ID: 22696878)
1. The effects of montelukast against amikacin-induced acute renal damage.
Kose E; Beytur A; Dogan Z; Ekincioglu Z; Vardi N; Cinar K; Turkoz Y; Soysal H; Ekinci N
Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):503-11. PubMed ID: 22696878
[TBL] [Abstract][Full Text] [Related]
2. Chronic renal failure-induced multiple-organ injury in rats is alleviated by the selective CysLT1 receptor antagonist montelukast.
Sener G; Sakarcan A; Sehirli O; Ekşioğlu-Demiralp E; Sener E; Ercan F; Gedik N; Yeğen BC
Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):257-67. PubMed ID: 17499745
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of montelukast against cisplatin-induced acute renal damage in rats.
Beytur A; Köse E; Sarihan ME; Sapmaz HI; Dogan Z; Cetin A; Vardi N; Turkoz Y; Ekinci N
Ren Fail; 2012; 34(3):343-9. PubMed ID: 22260262
[TBL] [Abstract][Full Text] [Related]
4. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist.
Tuğtepe H; Sener G; Cetinel S; Velioğlu-Oğünç A; Yeğen BC
Eur J Pharmacol; 2007 Feb; 557(1):69-75. PubMed ID: 17173892
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of pentoxyfilline in renal toxicity after methotrexate administration.
Asvadi I; Hajipour B; Asvadi A; Asl NA; Roshangar L; Khodadadi A
Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1003-9. PubMed ID: 22013722
[TBL] [Abstract][Full Text] [Related]
6. Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury.
Erşahin M; Çevik Ö; Akakın D; Şener A; Özbay L; Yegen BC; Şener G
Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):131-9. PubMed ID: 22986158
[TBL] [Abstract][Full Text] [Related]
7. Montelukast protects against renal ischemia/reperfusion injury in rats.
Sener G; Sehirli O; Velioğlu-Oğünç A; Cetinel S; Gedik N; Caner M; Sakarcan A; Yeğen BC
Pharmacol Res; 2006 Jul; 54(1):65-71. PubMed ID: 16584888
[TBL] [Abstract][Full Text] [Related]
8. Leukotriene receptor blocker montelukast protects against burn-induced oxidative injury of the skin and remote organs.
Sener G; Kabasakal L; Cetinel S; Contuk G; Gedik N; Yeğen BC
Burns; 2005 Aug; 31(5):587-96. PubMed ID: 15935562
[TBL] [Abstract][Full Text] [Related]
9. Montelukast reduces sepsis-induced lung and renal injury in rats.
Khodir AE; Ghoneim HA; Rahim MA; Suddek GM
Can J Physiol Pharmacol; 2014 Oct; 92(10):839-47. PubMed ID: 25243774
[TBL] [Abstract][Full Text] [Related]
10. Cysteinyl leukotriene receptor antagonist montelukast ameliorates acute lung injury following haemorrhagic shock in rats.
Al-Amran FG; Hadi NR; Hashim AM
Eur J Cardiothorac Surg; 2013 Feb; 43(2):421-7. PubMed ID: 22851661
[TBL] [Abstract][Full Text] [Related]
11. Gastroprotective effect of leukotriene receptor blocker montelukast in alendronat-induced lesions of the rat gastric mucosa.
Sener G; Kapucu C; Cetinel S; Cikler E; Ayanoğlu-Dülger G
Prostaglandins Leukot Essent Fatty Acids; 2005 Jan; 72(1):1-11. PubMed ID: 15589394
[TBL] [Abstract][Full Text] [Related]
12. Anti-apoptotic and anti-oxidant effects of grape seed proanthocyanidin extract in preventing cyclosporine A-induced nephropathy.
Ulusoy S; Ozkan G; Yucesan FB; Ersöz Ş; Orem A; Alkanat M; Yuluğ E; Kaynar K; Al S
Nephrology (Carlton); 2012 May; 17(4):372-9. PubMed ID: 22257215
[TBL] [Abstract][Full Text] [Related]
13. The protective effect of oxytocin on renal ischemia/reperfusion injury in rats.
Tuğtepe H; Sener G; Biyikli NK; Yüksel M; Cetinel S; Gedik N; Yeğen BC
Regul Pept; 2007 May; 140(3):101-8. PubMed ID: 17261335
[TBL] [Abstract][Full Text] [Related]
14. Stobadine protects rat kidney against ischaemia/reperfusion injury.
Guz G; Demirogullari B; Ulusu NN; Dogu C; Demirtola A; Kavutcu M; Omeroglu S; Stefek M; Karasu C
Clin Exp Pharmacol Physiol; 2007 Mar; 34(3):210-6. PubMed ID: 17250641
[TBL] [Abstract][Full Text] [Related]
15. Role of erythropoietin in prevention of amikacin-induced nephropathy.
Kaynar K; Aliyazioglu R; Ersoz S; Ulusoy S; Al S; Ozkan G; Cansiz M
J Nephrol; 2012; 25(5):744-9. PubMed ID: 22322815
[TBL] [Abstract][Full Text] [Related]
16. Renoprotective effects of montelukast, a cysteinyl leukotriene receptor antagonist, against methotrexate-induced kidney damage in rats.
Abdel-Raheem IT; Khedr NF
Naunyn Schmiedebergs Arch Pharmacol; 2014 Apr; 387(4):341-53. PubMed ID: 24363042
[TBL] [Abstract][Full Text] [Related]
17. Effects of pentoxifylline on amikacin-induced nephrotoxicity in rats.
Ozer MK; Asci H; Oncu M; Yesilot S; Savran M; Bayram D; Cicek E
Ren Fail; 2009; 31(2):134-9. PubMed ID: 19212910
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of sepsis-induced hepatic and ileal injury in rats by the leukotriene receptor blocker montelukast.
Sener G; Sehirli O; Cetinel S; Ercan F; Yüksel M; Gedik N; Yeğen BC
Prostaglandins Leukot Essent Fatty Acids; 2005 Dec; 73(6):453-62. PubMed ID: 16162403
[TBL] [Abstract][Full Text] [Related]
19. Protective Effects of Molsidomine Against Cisplatin-Induced Nephrotoxicity.
Karakoc HT; Altintas R; Parlakpinar H; Polat A; Samdanci E; Sagir M; Duran ZR
Adv Clin Exp Med; 2015; 24(4):585-93. PubMed ID: 26469102
[TBL] [Abstract][Full Text] [Related]
20. [Protective effect of melatonin against renal dysfunction following severe burn in rats].
Han XH; Wen GQ; Xu L
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Dec; 19(12):721-3. PubMed ID: 18093427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
